Withdrawal of Registration Statement (rw)
June 17 2022 - 4:06PM
Edgar (US Regulatory)
Biotech
Acquisition Company
545
West 25th Street, 20th Floor
New
York, New York 10001
June 17, 2022
Via
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporate Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Dillon Hagius
| |
Re: |
Biotech Acquisition Company |
| |
|
Request for Withdrawal of Registration Statement on Form S-4 |
| |
|
File No. 333-263577 |
Ladies
and Gentlemen:
On March 15, 2022, Biotech Acquisition
Company, a Cayman Islands exempted company (the “Company”), filed a Registration Statement on Form S-4 (File No. 333-263577)
(together with the exhibits, amendments and supplements thereto, the “Registration Statement”) under the Securities Act of
1933, as amended (the “Securities Act”), with the Securities and Exchange Commission. The Registration Statement was declared
effective on May 9, 2022. No securities have been issued or sold under the Registration Statement. Pursuant to Rule 477 under the Securities
Act, the Company hereby withdraws the Registration Statement.
Please
be advised that the solicitation of proxies with respect to an extraordinary general meeting of shareholders of the Company, referenced
in the Registration Statement, has terminated.
Please
feel free to contact Jonathan Deblinger, Esq., legal counsel to the Company, at 212-370-1300 if you have any questions. Thank you for
your assistance with this matter.
| |
Sincerely, |
| |
|
|
| |
Biotech Acquisition Company |
| |
|
|
| |
By: |
/s/ Michael Shleifer |
| |
|
Michael Shleifer |
| |
|
Chief Executive Officer |
| |
|
|
Biotech Acquisition (NASDAQ:BIOT)
Historical Stock Chart
From Dec 2024 to Jan 2025
Biotech Acquisition (NASDAQ:BIOT)
Historical Stock Chart
From Jan 2024 to Jan 2025
